Which of the following malignant tumors is radioresistant –
**Core Concept**
Radioresistance refers to the property of certain malignant tumors that are less responsive to the cytotoxic effects of ionizing radiation, making them more challenging to treat with radiation therapy. This phenomenon is attributed to various factors, including the tumor's histological characteristics, molecular profile, and the presence of specific genes that confer resistance to radiation-induced damage.
**Why the Correct Answer is Right**
Melanoma is a well-documented example of a radioresistant tumor. The primary reason for this radioresistance is the presence of high levels of melanin, a pigment that absorbs radiation and reduces its effectiveness. Additionally, melanoma cells often exhibit a high level of DNA repair mechanisms, which enable them to repair radiation-induced DNA damage more efficiently than other tumor cells. This combination of factors makes melanoma less responsive to radiation therapy compared to other tumor types.
**Why Each Wrong Option is Incorrect**
**Option A:** Sarcoma - Sarcomas are generally considered to be radiosensitive, meaning they respond well to radiation therapy. This is because many sarcomas are composed of undifferentiated cells that are more susceptible to radiation-induced damage.
**Option B:** Lymphoma - Lymphomas are also typically radiosensitive, particularly the Hodgkin lymphoma subtype. Radiation therapy is often used as a primary treatment modality for lymphomas, highlighting their responsiveness to ionizing radiation.
**Option C:** Carcinoma - Carcinomas, such as those originating from the breast, lung, or colon, are generally considered to be radiosensitive. Radiation therapy is often used in conjunction with surgery or chemotherapy to treat carcinomas, demonstrating their responsiveness to radiation.
**Clinical Pearl / High-Yield Fact**
Remember that radioresistance is not an absolute property of a tumor type but rather a spectrum of responsiveness to radiation. Factors such as tumor grade, stage, and molecular characteristics can influence a tumor's radiosensitivity, making it essential to consider individual patient factors when planning radiation therapy.
**Correct Answer:** A. Melanoma.